vs
帕可Bio（PACB）与REDWOOD TRUST INC（RWT）财务数据对比。点击上方公司名可切换其他公司
帕可Bio的季度营收约是REDWOOD TRUST INC的1.7倍（$44.6M vs $25.9M），REDWOOD TRUST INC净利率更高（77.2% vs -90.4%，领先167.7%），帕可Bio同比增速更快（13.8% vs -6.1%），过去两年帕可Bio的营收复合增速更高（7.3% vs -41.0%）
太平洋生物科学（加利福尼亚）公司是2004年成立的美国生物技术企业，专注于研发生产基因测序相关设备，还可实现新型实时生物观测。公司拥有两大核心测序平台：基于零模波导特性的单分子实时测序平台（SMRT），以及采用天然核苷酸、无损伤掺入完成DNA结合与延伸的结合测序技术（SBB）平台。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司，主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理，核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务，客户以机构投资者和房地产市场参与者为主。
PACB vs RWT — 直观对比
营收规模更大
PACB
是对方的1.7倍
$25.9M
营收增速更快
PACB
高出19.9%
-6.1%
净利率更高
RWT
高出167.7%
-90.4%
两年增速更快
PACB
近两年复合增速
-41.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $44.6M | $25.9M |
| 净利润 | $-40.4M | $20.0M |
| 毛利率 | 37.1% | — |
| 营业利润率 | -92.3% | — |
| 净利率 | -90.4% | 77.2% |
| 营收同比 | 13.8% | -6.1% |
| 净利润同比 | -1802.7% | 402.6% |
| 每股收益（稀释后） | $-0.11 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PACBRWT
| Q4 25 | $44.6M | $25.9M | ||
| Q3 25 | $38.4M | $15.0M | ||
| Q2 25 | $39.8M | $13.8M | ||
| Q1 25 | $37.2M | $27.9M | ||
| Q4 24 | $39.2M | $27.6M | ||
| Q3 24 | $40.0M | $25.5M | ||
| Q2 24 | $36.0M | $67.4M | ||
| Q1 24 | $38.8M | $74.5M |
净利润PACBRWT
| Q4 25 | $-40.4M | $20.0M | ||
| Q3 25 | $-38.0M | $-7.7M | ||
| Q2 25 | $-41.9M | $-98.5M | ||
| Q1 25 | $-426.1M | $16.1M | ||
| Q4 24 | $2.4M | $-6.6M | ||
| Q3 24 | $-60.7M | $14.8M | ||
| Q2 24 | $-173.3M | $15.5M | ||
| Q1 24 | $-78.2M | $30.3M |
毛利率PACBRWT
| Q4 25 | 37.1% | — | ||
| Q3 25 | 41.4% | — | ||
| Q2 25 | 36.9% | — | ||
| Q1 25 | -3.7% | — | ||
| Q4 24 | 25.6% | — | ||
| Q3 24 | 25.0% | — | ||
| Q2 24 | 16.5% | — | ||
| Q1 24 | 29.1% | — |
营业利润率PACBRWT
| Q4 25 | -92.3% | — | ||
| Q3 25 | -101.1% | -9.0% | ||
| Q2 25 | -112.8% | -679.0% | ||
| Q1 25 | -1154.5% | 80.2% | ||
| Q4 24 | -390.1% | -1.3% | ||
| Q3 24 | -160.3% | 86.1% | ||
| Q2 24 | -488.3% | 30.3% | ||
| Q1 24 | -209.6% | 41.3% |
净利率PACBRWT
| Q4 25 | -90.4% | 77.2% | ||
| Q3 25 | -98.9% | -51.4% | ||
| Q2 25 | -105.4% | -712.0% | ||
| Q1 25 | -1146.8% | 57.8% | ||
| Q4 24 | 6.0% | -24.0% | ||
| Q3 24 | -151.9% | 58.1% | ||
| Q2 24 | -481.3% | 23.0% | ||
| Q1 24 | -201.4% | 40.6% |
每股收益（稀释后）PACBRWT
| Q4 25 | $-0.11 | $0.11 | ||
| Q3 25 | $-0.13 | $-0.08 | ||
| Q2 25 | $-0.14 | $-0.76 | ||
| Q1 25 | $-1.44 | $0.10 | ||
| Q4 24 | $-0.44 | $-0.08 | ||
| Q3 24 | $-0.22 | $0.09 | ||
| Q2 24 | $-0.64 | $0.10 | ||
| Q1 24 | $-0.29 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $279.5M | $255.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $5.3M | $982.6M |
| 总资产 | $784.1M | $23.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PACBRWT
| Q4 25 | $279.5M | $255.7M | ||
| Q3 25 | $298.7M | $226.3M | ||
| Q2 25 | $314.7M | $302.0M | ||
| Q1 25 | $343.1M | $259.9M | ||
| Q4 24 | $389.9M | $245.2M | ||
| Q3 24 | $471.1M | $253.7M | ||
| Q2 24 | $509.8M | $275.6M | ||
| Q1 24 | $561.9M | $275.4M |
总债务PACBRWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $1.7B |
股东权益PACBRWT
| Q4 25 | $5.3M | $982.6M | ||
| Q3 25 | $36.1M | $999.0M | ||
| Q2 25 | $61.5M | $1.1B | ||
| Q1 25 | $91.6M | $1.2B | ||
| Q4 24 | $506.6M | $1.2B | ||
| Q3 24 | $453.1M | $1.2B | ||
| Q2 24 | $492.7M | $1.2B | ||
| Q1 24 | $649.0M | $1.2B |
总资产PACBRWT
| Q4 25 | $784.1M | $23.7B | ||
| Q3 25 | $803.2M | $22.6B | ||
| Q2 25 | $825.5M | $21.3B | ||
| Q1 25 | $860.8M | $19.9B | ||
| Q4 24 | $1.3B | $18.3B | ||
| Q3 24 | $1.5B | $18.4B | ||
| Q2 24 | $1.5B | $16.5B | ||
| Q1 24 | $1.7B | $15.1B |
负债/权益比PACBRWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.1M | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | — |
| 自由现金流率自由现金流/营收 | -44.6% | — |
| 资本支出强度资本支出/营收 | 1.9% | — |
| 现金转化率经营现金流/净利润 | — | -504.15× |
| 过去12个月自由现金流最近4个季度 | $-114.1M | — |
8季度趋势，按日历期对齐
经营现金流PACBRWT
| Q4 25 | $-19.1M | $-10.1B | ||
| Q3 25 | $-18.7M | $-2.7B | ||
| Q2 25 | $-29.4M | $-2.1B | ||
| Q1 25 | $-44.1M | $-2.0B | ||
| Q4 24 | $-30.6M | $-5.9B | ||
| Q3 24 | $-45.5M | $-2.1B | ||
| Q2 24 | $-54.3M | $-2.0B | ||
| Q1 24 | $-75.7M | $-954.2M |
自由现金流PACBRWT
| Q4 25 | $-19.9M | — | ||
| Q3 25 | $-18.8M | — | ||
| Q2 25 | $-29.9M | — | ||
| Q1 25 | $-45.4M | — | ||
| Q4 24 | $-32.3M | — | ||
| Q3 24 | $-46.3M | — | ||
| Q2 24 | $-55.7M | — | ||
| Q1 24 | $-79.6M | — |
自由现金流率PACBRWT
| Q4 25 | -44.6% | — | ||
| Q3 25 | -48.9% | — | ||
| Q2 25 | -75.3% | — | ||
| Q1 25 | -122.3% | — | ||
| Q4 24 | -82.3% | — | ||
| Q3 24 | -115.7% | — | ||
| Q2 24 | -154.8% | — | ||
| Q1 24 | -205.0% | — |
资本支出强度PACBRWT
| Q4 25 | 1.9% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | 4.1% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 4.1% | — | ||
| Q1 24 | 10.0% | — |
现金转化率PACBRWT
| Q4 25 | — | -504.15× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -120.92× | ||
| Q4 24 | -12.93× | — | ||
| Q3 24 | — | -140.86× | ||
| Q2 24 | — | -126.56× | ||
| Q1 24 | — | -31.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PACB
| Products | $39.0M | 87% |
| Service And Other | $5.7M | 13% |
RWT
暂无分部数据
